These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 3085875)

  • 41. [A case report of hereditary angioedema and studies on the serum components of complement, C1-inactivator and proteinase inhibitors during edema attack].
    Mikami A; Kohno M
    Hokkaido Igaku Zasshi; 1987 May; 62(3):497-500. PubMed ID: 3610041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. On the interaction between human plasma kallikrein and C1-esterase inhibitor.
    Nilsson T
    Thromb Haemost; 1983 Jun; 49(3):193-5. PubMed ID: 6554023
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-activity relationships in 3-isothiazolones.
    Morley JO; Oliver Kapur AJ; Charlton MH
    Org Biomol Chem; 2005 Oct; 3(20):3713-9. PubMed ID: 16211107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of acetylenic spirobutenolide derivatives and evaluation of their growth inhibitory effect on cells in culture.
    Bador P; Chantepie J; Paris J; Quash G
    Arzneimittelforschung; 1990 Oct; 40(10):1135-9. PubMed ID: 2291752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A method for the estimation of the activity of the inhibitor of the first component of complement.
    Smith AM; Thompson RA
    J Clin Pathol; 1980 Feb; 33(2):167-70. PubMed ID: 7364952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on piperidine derivatives. IV. Studies on the synthesis of 3-oxo-1-thia-4,8-diazaspiro (4,5)decane derivatives. 2].
    Nakanishi M; Arimura K
    Yakugaku Zasshi; 1971 Jun; 91(6):657-66. PubMed ID: 5104995
    [No Abstract]   [Full Text] [Related]  

  • 47. Detection of intermediary Clr with complete active site, using a synthetic proteinase inhibitor.
    Niinobe M; Ueno Y; Hitomi Y; Fujii S
    FEBS Lett; 1984 Jul; 172(2):159-62. PubMed ID: 6086386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Studies on fungicides. XXVI. Addition of 2,3-dimethylbutadiene to 5-methoxycarbonylmethylidene-2-thioxo-4-thiazolidones and 5-aroylmethylidene-2-thioxo-4-thiazolidones.
    Nagase H
    Chem Pharm Bull (Tokyo); 1974 Jul; 22(7):1661-3. PubMed ID: 4434595
    [No Abstract]   [Full Text] [Related]  

  • 49. Synthetic studies of bacitracin. IV. Synthesis of thiazoline peptides by iminoether coupling method.
    Hirotsu Y; Shiba T; Kaneko T
    Bull Chem Soc Jpn; 1967 Dec; 40(12):2945-9. PubMed ID: 5588232
    [No Abstract]   [Full Text] [Related]  

  • 50. [Molecular interaction between synthetic spirobutenolides and C1 esterase normal inhibitor].
    Bador P; Ollier-Hartmann MP; Paris J; Hartmann L
    C R Acad Sci III; 1986; 303(3):55-8. PubMed ID: 3093005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New preparation method of C1 esterase for the dosage of its plasma inhibitor].
    Gozin D; Ollier-Hartmann MP; Lerable J; Hartmann L; Soulier JP
    Biomed Pharmacother; 1983; 37(5):228-30. PubMed ID: 6607074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum C1-esterase inhibitor (C1INH) levels in normal adults.
    Ongaro G; Calabrò A; Panunzio MT
    Quad Sclavo Diagn; 1982 Mar; 18(1):104-13. PubMed ID: 6818608
    [No Abstract]   [Full Text] [Related]  

  • 53. Changes of C1 esterase inhibitor, alpha2 globulin and sedimentation rate after severe brain injury.
    Spiteri D; Viola L; Allegretti De Lista G; Galloro F; Schisano G
    Acta Neurol (Napoli); 1983 Dec; 5(6):420-5. PubMed ID: 6199953
    [No Abstract]   [Full Text] [Related]  

  • 54. [Proposal for a new synthetic inhibitor of C1 esterase, methyl-2 thiazoline carbamic ester-3 spirobutenolide: enzyme and electron studies].
    Ollier-Hartmann MP; Rocher JP; Tinland B; Hartmann L; Paris J
    C R Acad Sci III; 1986; 302(10):369-74. PubMed ID: 3085875
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.